过去一年中添加的文章,按日期排序

Smart nanozymes coupled with dynamic magnet field and laser exposures for cancer therapy

M Wang, J Li, J Liu, Y Huang, L Yang, C Zhu… - Journal of Colloid and …, 2024 - Elsevier
1 天前 - … We showed that the laryngeal carcinoma tumor growth in mice was significantly
inhibited, and even the tumors disappeared after the tumors were locally exposed to magnetic …

[HTML][HTML] Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM …

HJ Jeon, D Lim, EA So, S Kim, JH Jeong… - … Pharmaceutica Sinica B, 2024 - Elsevier
2 天前 - … in tumor-rechallenged mice. Our findings demonstrate superiority of the engineered
Salmonella as a cancer … Finally, tumor growth was not observed in the tumor-bearing mice, …

[HTML][HTML] Inhibition of Notch4 using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium

JWL Eng, Y Kato, Y Adachi, B Swaminathan… - Cancer Research … - aacrjournals.org
2 天前 - … delayed tumor growth in mouse models of breast, skin, and lung cancer. Enhanced
… We conclude that targeting Notch4 improves tumor growth control through endothelial …

[HTML][HTML] Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer

J Zhou, S Wan, Y Wu, H Hu, Y Liu, Z Liao, M Xu… - Biomedicine & …, 2024 - Elsevier
2 天前 - tumor growth inhibition rate (73.00 %) with good safety in the tumor-bearing mice,
which … PTX delivery and demonstrated a promising strategy for the targeted cancer treatment. …

CLEC18A interacts with sulfated GAGs and controls clear cell renal cell carcinoma progression

G Jonsson, M Hofmann, S Mereiter, L Hartley-Tassell… - bioRxiv, 2024 - biorxiv.org
2 天前 - mouse models of ccRCC, deletion of the mouse ortholog Clec18a resulted in enhanced
tumor growth. … of Clec18a promoted tumor growth of RAG ccRCC cancer cells following …

[PDF][PDF] TLE4 downregulation identified by WGCNA and machine learning algorithm promotes papillary thyroid carcinoma progression via activating JAK/STAT pathway

J Lin, B Cai, Q Lin, X Lin, B Wang, X Chen - Journal of Cancer, 2024 - jcancer.org
2 天前 - … subcutaneously into the mice. Tumor growth was monitored by measuring tumor
volume and … The nude mouse study in this article was reviewed and approved by the Ethics …

[HTML][HTML] Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy

M Peipp, D Dudziak, C Kellner - Signal Transduction and Targeted …, 2024 - nature.com
2 天前 - … In tumor cDC1, transforming growth factor (TGF)-β promotes … In mice harboring
MCA191-OVA tumors anti-DEC205/pSAP enhanced T cell activation and reduced tumor growth

[HTML][HTML] Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis

C Yang, L Yang, LI Dihua, J Tan, Q Jia, H Sun, Z Meng… - Heliyon, 2024 - cell.com
2 天前 - … in tumor suppression, providing new avenues for cancer … the mechanism of anti-tumor
effect of SKN in ATC cells … BALB/C nude mice subcutaneous tumor model to analyse the …

Mitochondria mediated inhibitory effect of Nyctanthes arbor-tristis (L.) flower extract against breast adenocarcinoma and T-cell lymphoma: an in vitro and in vivo study

P Goswami, V Singh, B Koch - Journal of Ethnopharmacology, 2024 - Elsevier
2 天前 - mice while reducing tumor load and belly size growthtumor load of mice, enhances
survivability and could be a promising agent against the triple negative breast cancer and …

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion

Z Chen, M Yu, B Zhang, L Jin, Q Yu, S Liu… - …, 2024 - Taylor & Francis
3 天前 - tumor growth and reinvigorate CD8+ T cell cytotoxicity. Anti-SIGLEC15 treatment
could effectively inhibit tumor growth in mouse … of immunotherapy efficacy across cancer types, …